United States - English - NLM (National Library of Medicine)

alcon, inc. - fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir) - fluorescite® injection 10% is indicated in diagnostic fluorescein angiography or angioscopy of the retina and iris vasculature. fluorescite® injection 10% is contraindicated in patients with known hypersensitivity to fluorescein sodium or any other ingredients in this product. rare cases of death due to anaphylaxis have been reported. [see warnings and precautions (5.1) and adverse reactions (6)]. fluorescein sodium can induce serious intolerance reactions. these reactions of intolerance are always unpredictable but they are more frequent in patients who have previously experienced an adverse reaction after fluorescein injection (symptoms other than nausea and vomiting) or in patients with history of allergy such as food or drug induced urticaria, asthma, eczema, allergic rhinitis. detailed questioning of each patient is recommended before the angiography to evaluate any prior history of allergy. adequate animal reproduction studies have not been conducted with fluorescein sodium.  it is also not known whether fluorescein sodium can cause fetal harm when administered to a pregnant woman. fluorescein sodium should be given to a pregnant woman only if clearly needed. fluorescein sodium injection has been demonstrated to be excreted in human milk for up to 4 days.  following fluorescein angiography, breast-feeding should therefore be discontinued for at least 4 days and the milk should be pumped off and discarded during this period. pediatric patients have been included in clinical studies.  no overall differences in safety or effectiveness have been observed between pediatric and adult patients. no overall differences in safety or effectiveness have been observed between elderly and other adult patients.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

santen oy - oxybuprocaine hydrochloride 3 mg/ml; fluorescein sodium 1,25 mg/ml - eye drops, solution - 1,25 mg/ml - 3 mg/ml - fluorescein sodium 1.25 mg/ml; oxybuprocaine hydrochloride 3 mg/ml - fluorescein, combinations

New Zealand - English - Medsafe (Medicines Safety Authority)

alcon laboratories australia pty ltd (nz) - fluorescein sodium 25%{relative} - solution for injection - 25 % - active: fluorescein sodium 25%{relative} excipient: hydrochloric acid as 1n solution, to ph 9.0-9.8 sodium hydroxide as 1n solution, to ph 9.0-9.8 water for injection

Singapore - English - HSA (Health Sciences Authority)

bausch & lomb (singapore) private limited - fluorescein sodium - solution - 2% w/v - fluorescein sodium 2% w/v

Australia - English - Department of Health (Therapeutic Goods Administration)

optimed pty ltd - 33737 - fluorescein strip - a small absorbent strip, made of filter paper or similar material, that is impregnated with a small amount of fluorescein sodium which functions as a dye frequently used in ophthalmic examinations of the anterior segment of the eye.

Australia - English - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 33737 - fluorescein strip - a fluorescein sodium ophthalmic diagnostic strip used for evaluation and examination of the eye when fitting contact lenses.

Australia - English - Department of Health (Therapeutic Goods Administration)

optimed pty ltd - 33737 - fluorescein strip - a small absorbent strip, made of filter paper or similar material, that is impregnated with a small amount of fluorescein sodium or lissamine green which functions as a dye frequently used in ophthalmic examinations of the anterior segment of the eye.

United States - English - NLM (National Library of Medicine)

ocusoft, inc. - fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir), proparacaine hydrochloride (unii: u96ol57goy) (proparacaine - unii:b4ob0jhi1x) - for procedures requiring a disclosing agent in combination with an anesthetic agent such as tonometry, gonioscopy, removal of corneal foreign bodies and other short corneal or conjunctival procedures. known hypersensitivity to any component of this product.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

chauvin bausch & lomb, united kingdom - fluorescein sodium - eye drops, solution - 2 %

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

chauvin bausch & lomb, united kingdom - fluorescein sodium,lidocaine hydrochloride - eye drops, solution - 4,0.25 %,